Alpha Tau Medical Ltd.
DRTS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $217 | $208 | $202 | $398 |
| - Cash | $14 | $13 | $6 | $23 |
| + Debt | $13 | $13 | $5 | $54 |
| Enterprise Value | $216 | $209 | $201 | $429 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$30 | -$28 | -$33 | -$13 |
| % Margin | – | – | – | – |
| Net Income | -$32 | -$29 | -$34 | -$27 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.45 | -0.42 | -0.53 | -0.67 |
| % Growth | -7.1% | 20.8% | 20.9% | – |
| Operating Cash Flow | -$20 | -$18 | -$24 | -$12 |
| Capital Expenditures | -$2 | -$6 | -$1 | -$3 |
| Free Cash Flow | -$22 | -$24 | -$25 | -$15 |